Series C funding round for Checkmate Pharmaceuticals raising $85M in June 2020
Series C funding round for Checkmate Pharmaceuticals raising $85M in June 2020
| Investor | Firm Type | Partner |
|---|
Novo VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Jason Wang | |
| Angel | Jon Brelig | |
| Angel | Carol Gallagher | |
| Angel | James Park | |
| Angel | Ralph Gootee | |
| Angel | Manik Gupta |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Checkmate Pharmaceuticals raised $85M in a Series C round.
The round was announced on 06/01/20.
The round was led by Oren K. Isacoff, M.D., Nilesh Kumar.